Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director | April 26, 2013 | April 30, 2013 |
| Walmart Inc.WMT · Entity 783 | Director | June 03, 2005 | June 07, 2005 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date April 26, 2013 · Filed April 30, 2013
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,520 |
Reported balance
After 2013-04-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2013-04-26 · Grant · Acquired 1,845 · Balance 25,520 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2: These shares include 208 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
F2: These shares include 208 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Walmart Inc.
Report date June 03, 2005 · Filed June 07, 2005
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,898.71 |
Reported balance
After 2005-06-03 transaction · row 1
1 source rowRow 1 · 2005-06-03 · Grant · Acquired 2,956.71 · Balance 7,898.71 F1: Each outside director is entitled to $140,000 of stock as part of his or her annual retainer. |
Filing footnotes · ownership attribution and instrument terms
F1: Each outside director is entitled to $140,000 of stock as part of his or her annual retainer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2004 Filed Mar 16, 2004 22:03 UTC | AMGEN INC AMGN · Entity 2832 | GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015950 · rrd36768.xml · nonDerivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RUSs vest (a) immediately for directors who have three years or more of prior continuous service as a director. or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payments is otherwise deferred by the director. Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $50.78 | $0.00 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · derivative · entry 12 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2013-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 67 | $65.12 | $4,363.04 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 11 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50 Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,600 | $65.10 | $104,160.00 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 10 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117 Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $65.14 | $6,514.00 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 9 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,717 Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $65.17 | $6,517.00 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 8 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,817 Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 200 | $65.16 | $13,032.00 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 7 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,917 Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $65.20 | $6,520.00 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 6 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,117 Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $65.25 | $6,525.00 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 5 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,217 Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 6,700 | $65.28 | $437,376.00 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 4 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,317 Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 690 | $65.27 | $45,036.30 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 3 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,017 Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 6,343 | $65.13 | $413,119.59 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,707 Read SEC document |
| February 17, 2004 Filed Apr 6, 2004 21:12 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 16,000 | $50.78 | $812,480.00 |
DisclosureSEC source: 0001181431-04-019598 · rrd38876.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2003 Filed Jun 10, 2003 16:11 UTC | Walmart Inc. WMT · Entity 783 | GrantCommon Stock | 1,951 | $53.83 | $105,022.33 |
DisclosureSEC source: 0001184127-03-000001 · doc4.xml · nonDerivative · entry 1 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,893 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.